Pimentel: Sue Sanofi over refusal to fully refund Dengvaxia payments | Inquirer News
Sunday, August 19, 2018
Close  
  • share this

Pimentel: Sue Sanofi over refusal to fully refund Dengvaxia payments

By: - Reporter / @MAgerINQ
/ 02:16 PM February 05, 2018

French pharmaceutical giant Sanofi Pasteur should be sued “even in international courts” after it refused to refund the full amount of money spent by the government to purchase anti-dengue vaccine, Dengvaxia, Senate President Aqulino “Koko” Pimentel III said on Monday.

In a statement, Sanofi said that “agreeing to refund the used doses of Dengvaxia would imply that the vaccine is ineffective, which is not the case.”

Sought for comment, Pimentel said in a text message: “Then they should be sued.”

ADVERTISEMENT

Asked if the case should be separate from the charges already filed against the drug company, the Senate leader said: “Civil case, maybe even in international courts. Let us look at the grievance procedure in the contract.”

Earlier, Pimentel had urged the Department of Health (DOH) to demand for the refund of the entire cost of Dengvaxia purchase, and not only seek for the refund of unused vaccines.

READ: Pimentel urges DOH to demand full refund from Sanofi

Health officials previously disclosed that Sanofi had returned P1.6 billion worth of unused Dengvaxia, which, they said, was deposited to the Bureau of Treasury.   /kga

Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: anti-dengue, Dengvaxia, refund, Sanofi Pasteur, Senator Koko Pimentel, vaccine
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2018 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.